Skip to content

Celia J. A. Morgan

45 papers in the library · 2,248 citations · publishing 2009-2026

Papers

Sort Most recent Most cited

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.

Translational Psychiatry September 5, 2018 Celia J. A. Morgan, Tom P. Freeman, Chandni Hindocha et al.

The main active ingredient in cannabis, delta-9-tetrahydrocannabinol (THC), can acutely induce psychotic symptoms and impair episodic and working memory. Another major constituent, cannabidiol (CBD), may attenuate these effects. This study aimed to determine the effects of THC and CBD, both alone and in combination on psychotic symptoms and memory function. A randomised, double-blind crossover...

Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?

Psychological Medicine September 4, 2018 Helen Valerie Curran, Chandni Hindocha, Celia J. A. Morgan et al. 65 citations

BACKGROUND: Changes in cannabis regulation globally make it increasingly important to determine what predicts an individual's risk of experiencing adverse drug effects. Relevant studies have used diverse self-report measures of cannabis use, and few include multiple biological measures. Here we aimed to determine which biological and self-report measures of cannabis use predict cannabis...

Author Correction: Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey

Scientific Reports February 28, 2018 Will Lawn, Jaime E. C. Hallak, José A. Crippa et al. 3 citations

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey

Scientific Reports November 3, 2017 Will Lawn, Jaime E. C. Hallak, José Alexandre S. Crippa et al. 78 citations

Abstract Ayahuasca is a natural psychedelic brew, which contains dimethyltryptamine (DMT). Its potential as a psychiatric medicine has recently been demonstrated and its non-medical use around the world appears to be growing. We aimed to investigate well-being and problematic alcohol use in ayahuasca users, and ayahuasca’s subjective effects. An online, self-selecting, global survey examining...

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion

The International Journal of Neuropsychopharmacology August 30, 2017 Tom P. Freeman, Rebecca Pope, Matthew B. Wall et al. 67 citations

Background: Despite the current shift towards permissive cannabis policies, few studies have investigated the pleasurable effects users seek. Here, we investigate the effects of cannabis on listening to music, a rewarding activity that frequently occurs in the context of recreational cannabis use. We additionally tested how these effects are influenced by cannabidiol, which may offset...

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.

The Lancet Psychiatry April 5, 2017 Ilina Singh, Celia J. A. Morgan, Valerie H. Curran et al. 158 citations

We present a review and analysis of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression. The analysis of ethical considerations is contextualised in an overview of the evidence for ketamine use in depression, and a review of the drug's safety profile. We find that, based on current evidence, ketamine use for severe, treatment-resistant depression does...

DOI: 10.1016/s2215-0366(17)30102-5 (opens in new tab) Ketamine treatment ketamine Powerful intervention Fast-acting antidepressant effects Depression treatment depression +9

A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial

Trials April 4, 2017 Amy Mcandrew, Will Lawn, Tobias Stevens et al. 20 citations

BACKGROUND: Worldwide, alcohol abuse is a burgeoning problem. Abstinence is key to allow recovery of physical and mental health as well as quality of life, but treatment for alcohol dependence is associated with high relapse rates. Preliminary data have suggested that a combined repeated ketamine and psychological therapy programme may be effective in reducing relapse in severe alcohol use...

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses

Psychopharmacology September 2, 2016 Will Lawn, Tom P. Freeman, Rebecca Pope et al. 177 citations

RATIONALE: Anecdotally, both acute and chronic cannabis use have been associated with apathy, amotivation, and other reward processing deficits. To date, empirical support for these effects is limited, and no previous studies have assessed both acute effects of Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), as well as associations with cannabis dependence. OBJECTIVES: The objectives of...

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.

European Neuropsychopharmacology March 2015 Chandni Hindocha, Tom P. Freeman, Gráinne Schäfer et al.

Acute administration of the primary psychoactive constituent of cannabis, Δ-9-tetrahydrocannabinol (THC), impairs human facial affect recognition, implicating the endocannabinoid system in emotional processing. Another main constituent of cannabis, cannabidiol (CBD), has seemingly opposite functional effects on the brain. This study aimed to determine the effects of THC and CBD, both alone and...

DOI: 10.1016/j.euroneuro.2014.11.014 (opens in new tab) Full text (opens in new tab) Cannabidiol CBD Emotional processing Endocannabinoid system Schizotypy +1

Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

Addiction October 2014 Tom P. Freeman, Celia J. A. Morgan, Chandni Hindocha et al.

(1) To determine whether measured concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in individuals' own cannabis predict their estimates of drug potency and actual titration; and (2) to ascertain if these effects are influenced by frequency of use and cannabis type. Cross-sectional, naturalistic. Participants' own homes. A total of 247 cannabis users in the United...

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

Biological Psychiatry January 10, 2014 Robin Carhart-Harris, Kevin Murphy, Robert Leech et al. 182 citations

The MTLs appear to be specifically implicated in the mechanism of action of MDMA, but further work is required to elucidate how the drug's characteristic subjective effects arise from its modulation of spontaneous brain activity.

DOI: 10.1016/j.biopsych.2013.12.015 (opens in new tab) MDMA Euphoriant Cerebral blood flow Amygdala +5

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories

The International Journal of Neuropsychopharmacology December 17, 2013 Robin Carhart-Harris, Matthew B. Wall, David Erritzøe et al. 110 citations

3,4-methylenedioxymethamphetamine (MDMA) is a potent monoamine-releaser that is widely used as a recreational drug. Preliminary work has supported the potential of MDMA in psychotherapy for post-traumatic stress disorder (PTSD). The neurobiological mechanisms underlying its putative efficacy are, however, poorly understood. Psychotherapy for PTSD usually requires that patients revisit traumatic...

Investigating the interaction between schizotypy, divergent thinking and cannabis use

Consciousness and Cognition January 10, 2012 Gráinne Schäfer, Amanda Feilding, Celia J. A. Morgan et al. 60 citations

Cannabis acutely increases schizotypy and chronic use is associated with elevated rates of psychosis. Creative individuals have higher levels of schizotypy, however links between cannabis use, schizotypy and creativity have not been investigated. We investigated the effects of cannabis smoked naturalistically on schizotypy and divergent thinking, a measure of creativity. One hundred and sixty...

Association of study characteristics with estimates of effect size in studies of ecstasy use.

Journal of Psychopharmacology November 2011 Eleanor M Taylor, Natasha M P Greene, Celia J. A. Morgan et al.

Studies of the chronic effects of MDMA, or 'ecstasy', in humans have been largely inconsistent. We explored whether study-level characteristics are associated with the effect size estimate reported. We based our analyses on the recent systematic review by Rogers and colleagues, focusing on those meta-analyses within this report where there was a relatively large number of studies contributing...

Using Ketamine to Model Semantic Deficits in Schizophrenia

Journal of Clinical Psychopharmacology October 21, 2011 Erica Neill, Susan Lee Rossell, Sarah McDonald et al. 11 citations

Semantic deficits constitute a core cognitive abnormality in schizophrenia. In the current study, the N-methyl-d-aspartate receptor antagonist ketamine was administered to healthy individuals acutely while they performed semantic processing tasks that included word pairs of differing degrees of semantic relatedness. Two dimensions of semantic processing were investigated: (1) explicit versus...

Ketamine use: a review

Addiction July 21, 2011 Celia J. A. Morgan, Helen Valerie Curran 645 citations

AIMS: Ketamine remains an important medicine in both specialist anaesthesia and aspects of pain management. At the same time, its use as a recreational drug has spread in many parts of the world during the past few years. There are now increasing concerns about the harmful physical and psychological consequences of repeated misuse of this drug. The aim of this review was to survey and integrate...

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

The British Journal of Psychiatry October 2010 Celia J. A. Morgan, Gráinne Schäfer, Tom P. Freeman et al.

The two main constituents of cannabis, cannabidiol and Δ(9)-tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid. To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings. Cannabis...

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.

Addiction January 2010 Celia J. A. Morgan, Leslie Muetzelfeldt, Helen Valerie Curran

'Recreational' use of ketamine is spreading rapidly among young people. In healthy individuals an acute dose of the N-methyl D-aspartate (NMDA) receptor antagonist ketamine induces marked psychosis-like effects and cognitive impairments, but little is known about the long-term effects of the drug. To evaluate the long-term neuropsychiatric or cognitive consequences. A total of 150 individuals...

Harms associated with psychoactive substances: findings of the UK National Drug Survey

Journal of Psychopharmacology November 25, 2009 Celia J. A. Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt et al. 80 citations

Nutt and colleagues' 'rational' scale to assess the harms of commonly used drugs was based on ratings by a panel of experts. This survey aimed to assess drug users' views of the harms of drugs using the same scale. As users' drug choices are not solely based on harms, we additionally assessed perceived benefits. The survey was hosted at http://www.nationaldrugsurvey.org. UK residents reported...

The incidence of unpleasant dreams after sub-anaesthetic ketamine.

Psychopharmacology March 1, 2009 Mark Blagrove, Celia J. A. Morgan, Helen Valerie Curran et al.

Ketamine is an N-methyl-D: -aspartate (NMDA) receptor antagonist with psychotogenic effects and for which there are diverse reports of whether pleasant or unpleasant dreams result during anaesthesia, post-operatively or after sub-anaesthetic use. To assess in healthy volunteers the incidence of unpleasant dreams over the three nights after receiving a sub-anaesthetic dose of ketamine, in...